Pancreatic cancer screening employing noncontrast magnetic resonance imaging combined with ultrasonography

Japanese Journal of Radiology

Volumn 29, Issue 4, 2011, Pages 265-271

  Kuroki Suzuki, Seiko ^a   Kuroki, Yoshifumi ^b   Nasu, Katsuhiro ^c   Nagashima, Chieko ^a   MacHida, Minoru ^a   Muramatsu, Yukio ^a   Moriyama, Noriyuki ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b TOCHIGI CANCER CENTER   (Japan)

^c UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

Cancer screening; Diffusion weighted imaging (DWI); MRI; Pancreatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES;

EID: 79960030585     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-010-0554-6     Document Type: Article

References (25)

1. Lowenfels AB, Maisonneuve P, Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:197-209.
2. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-303.
3. Samkoe KS, Chen A, Rizvi I, O'Hara JA, Hoopes PJ, Pereira SP, et al. Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys 2009;76:251-9.
4. Sultana A, Tudur Smith C, Cunningham D, Starling N, Neoptolemos JP, Ghaneh P. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br J Cancer 2008;99:6-13. (Pubitemid 351920234)
5. Li J, Saif MW. Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May29-June 2, 2009. JOP 2009;10:361-5.
6. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009;20;5487-91.
7. Rivera F, López-Tarruella S, Vega-Villegas ME, Salcedo M. Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy. Cancer Treat Rev 2009;35:335-9.
8. Loos M, Friess H, Kleeff J. Surgery of malignant pancreatic tumors. Radiologe 2009;49:137-43.
9. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586-94. (Pubitemid 38624667)
10. Li CI, Malone KE, Weiss NS, Daling JR. Use of tamoxifen for primary breast cancer in relation to risk of contralateral breast cancer. J Natl Cancer Inst 2001;93:1008-13. (Pubitemid 32677400)
11. Kollias J, Ellis IO, Elston CW, Blamey RW. Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 2001;25:1117-24. (Pubitemid 32845821)
12. Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 2001;51:679-90.
13. Yahalom J, Petrek JA, Biddinger PW, Kessler S, Dershaw DD, McCormick B, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992;10:1674-81. (Pubitemid 23059943)
14. Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007;6:21-7.
15. Inamoto Y, Kawamura S. An investigation into the actual condition of pancreatic cancers detected by mass-screening. Nippon Shokaki-shuudankenshin Gakkaishi 1992;96:88-94 (in Japanese).
16. Tanaka S, Nakaizumi A, Ioka T, Takakura R, Uehara H, Nakao M, et al. Periodic ultrasonography checkup for the early detection of pancreatic cancer: preliminary report. Pancreas 2004;28:268-72. (Pubitemid 38437321)
17. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-86. (Pubitemid 32423354)
18. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-87. (Pubitemid 38971421)
19. Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447:794-9. (Pubitemid 41728866)
20. Fukushima N, Fukayama M. Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics. J Hepatobiliary Pancreat Surg 2007;14:238-42. (Pubitemid 46863912)
21. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788-97.
22. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-81. (Pubitemid 43825802)
23. Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas.Pancreatology 2002;2:484-90.
24. Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008;57:1561-5.
25. Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2005;28:5688-90. (Pubitemid 41684925)